Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$329,648
+$3,631 QoQ
Shares Held
1,310
-12.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#3,540
of 4,150 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Signature Equity Partners, LLC holds $2,503,539 across 16 Drug Manufacturers - General names. ABBV ranks #4 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
730 | $875,583 | |
| 2 | JNJ |
Johnson & Johnson
|
2,026 | $514,543 | |
| 3 | AMGN |
Amgen Inc
|
965 | $349,445 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
1,310 | $329,648 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,008 | $129,528 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
2,134 | $122,961 | |
| 7 | AZN |
Astrazeneca PLC
|
270 | $51,197 | |
| 8 | NVS |
Novartis AG
|
240 | $37,612 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $329,648 | 1,310 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $326,017 | 1,499 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $364,213 | 1,594 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||